Medicare Enrolled
Dr. Leigh Bergmann, M.D.
Urology Physician · Bryn Mawr, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bergmann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bergmann?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bergmann
Dr. Leigh Bergmann is an urology physician in Bryn Mawr, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bergmann performed 11,085 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bergmann received a total of $10,340 from 69 pharmaceutical and/or device companies across 460 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bergmann is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 2% volume in PA
$10,340 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗11,085
Medicare services
Top 2% in PA for urology physician
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 3,375 | $2 | $7 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,892 | $3 | $14 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,760 | $9 | $119 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,391 | $97 | $288 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
745 | $8 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
552 | $66 | $199 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
403 | $51 | $137 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
171 | $67 | $420 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
163 | $11 | $178 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
126 | $119 | $387 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
72 | $71 | $266 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 58 | $133 | $819 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
53 | $107 | $607 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
41 | $52 | $179 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
36 | $26 | $441 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
35 | $12 | $76 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
34 | $29 | $101 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
34 | $66 | $167 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $137 | $409 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
31 | $64 | $262 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $83 | $276 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
17 | $25 | $158 |
| Insertion of temporary bladder tube | 16 | $38 | $146 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $109 | $341 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $44 | $116 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,340
Total received (2018-2024)
Avg $1,477/year across 7 years
Top 14% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
460
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,680
2023
$1,434
2022
$983
2021
$862
2020
$645
2019
$2,156
2018
$2,580
Payments by company (2024)
Tolmar, Inc.
$198
Bayer Healthcare Pharmaceuticals Inc.
$182
ABBVIE INC.
$174
PFIZER INC.
$141
Astellas Pharma US Inc
$128
Sumitomo Pharma America, Inc.
$114
Janssen Biotech, Inc.
$102
BIOPROTECT MEDICAL, INC.
$97
UROGEN PHARMA, INC.
$93
Dendreon Pharmaceuticals LLC
$92
PROGENICS PHARMACEUTICALS, INC.
$82
AstraZeneca Pharmaceuticals LP
$70
Telix Pharmaceuticals
$45
Olympus America Inc.
$37
IMMUNITYBIO, INC.
$30
Calyxo, Inc.
$20
VERTEX PHARMACEUTICALS INCORPORATED
$18
Boston Scientific Corporation
$17
Teleflex LLC
$15
COLOPLAST CORP
$14
PROCEPT BioRobotics Corporation
$13
Top 3 companies account for 33.0% of 2024 payments
All-time payments by company (2018-2024) ›
Dendreon Pharmaceuticals LLC
$1,140
Astellas Pharma US Inc
$1,092
Janssen Biotech, Inc.
$947
PFIZER INC.
$718
KARL STORZ Endoscopy-America
$654
Ferring Pharmaceuticals Inc.
$455
Medtronic, Inc.
$399
Amgen Inc.
$315
Endo Pharmaceuticals Inc.
$299
Tolmar, Inc.
$295
Bayer HealthCare Pharmaceuticals Inc.
$260
Sumitomo Pharma America, Inc.
$228
ABBVIE INC.
$218
AstraZeneca Pharmaceuticals LP
$209
Bayer Healthcare Pharmaceuticals Inc.
$205
Avadel Specialty Pharmaceuticals, LLC
$203
Mission Pharmacal Company
$176
Boston Scientific Corporation
$171
UROVANT SCIENCES INC
$146
TOLMAR Pharmaceuticals, Inc.
$138
Cook Medical LLC
$132
Merck Sharp & Dohme Corporation
$119
UROGEN PHARMA, INC.
$116
BIOPROTECT MEDICAL, INC.
$97
Telix Pharmaceuticals
$84
Blue Earth Diagnostics Limited
$84
BAXTER HEALTHCARE
$84
PROGENICS PHARMACEUTICALS, INC.
$82
Agiliti Surgical, Inc.
$80
180 Medical, Inc.
$77
Merck Sharp & Dohme LLC
$69
Sun Pharmaceutical Industries Inc.
$63
Teleflex LLC
$61
Rochester Medical Corporation
$52
MEDIVATION FIELD SOLUTIONS LLC
$45
Allergan Inc.
$45
AbbVie Inc.
$41
Aytu BioScience, Inc
$40
Coloplast Corp
$38
AbbVie, Inc.
$37
Laborie Medical Technologies Corp.
$37
Olympus America Inc.
$37
Baxter Healthcare
$36
Prometheus Laboratories Inc.
$35
C. R. BARD, INC. & SUBSIDIARIES
$34
Clinigen Inc
$32
IMMUNITYBIO, INC.
$30
Progenics Pharmaceuticals, Inc.
$25
Photocure Inc
$25
Acerus Pharmaceuticals Corporation
$24
NeoTract Inc.
$22
Accord Healthcare, Inc.
$22
KCI USA, Inc
$20
Calyxo, Inc.
$20
BOSTON SCIENTIFIC CORPORATION
$19
Antares Pharma, Inc.
$19
VERTEX PHARMACEUTICALS INCORPORATED
$18
CONMED Corporation
$18
Allergan, Inc.
$17
Medtronic USA, Inc.
$16
Clovis Oncology, Inc.
$15
ACCORD HEALTHCARE, INC.
$15
C. R. Bard, Inc. & Subsidiaries
$14
COLOPLAST CORP
$14
SRS Medical Systems, Inc.
$14
PROCEPT BioRobotics Corporation
$13
UroGen Pharma, Inc.
$13
Amniox Medical, Inc.
$12
Janssen Scientific Affairs, LLC
$10
Top 3 companies account for 30.7% of all-time payments
Associated products mentioned in payments ›
0.30MM · 16 FR. FLEXIBLE VIDEO CYSTOSCOPE · 16 FR. FLEXIBLE VIDEO CYSTOSCOPE · 22FR · 24/26 FR. · 30'AUTOCLAV · 4mm · 7 FR X 40CM · AIRSEAL · ALTIS · AMS · ANKTIVA · AQUABEAM SYSTEM · Androgel · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BIPOLAR · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CONTINENCE CARE · CUTTING LOOP · CVAC ASPIRATION SYSTEM · CYSTO-URETHRO-FIBERSCOPE · CYSTOSCOPE-URETHROSCOPE SHEATH ONLY · CYSVIEW · Cook · Cysview · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM · FLEXIBLE · FLOSEAL · FORCEPS · GEMTESA · GENERAL ONCOLOGY · GENERAL UTERINE TISSUE REMOVAL · GENERAL ERECTILE DYSFUNCTION · GENTLECATH · GRASPING · GREENLIGHT HOPKINS II OPTIK 30 · GentleCath · HOPKINS · ILLUCCIX · IMFINZI · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · Luja Coude · MAGIC3 · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · OTREXUP · PREVENA · PROVENGE · PYLARIFY · Proleukin · Prolia · Rezum Generator · SPEEDICATH · SUTENT · SpaceOAR System · Spanner Prothetic Stent · TELESCOPE · TISSEEL · TOVIAZ · UROLIFT · Uribel · UroLift · UroLift System · Urocit-K · VESICARE · Veozah · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · YONSA (abiraterone acetate) · ZYTIGA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
306
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bergmann is a clinical cardiology specialist, with above-average Medicare volume (top 2% in PA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bergmann experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Bergmann performed 3,375 bcg treatment for bladder cancer services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bergmann receive payments from pharmaceutical companies?
Yes. Dr. Bergmann received a total of $10,340 from 69 companies across 460 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bergmann's costs compare to other urology physicians in Bryn Mawr?
Dr. Bergmann's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bergmann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Bryn Mawr
Browse urology physicians in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology